DEPARTMENT OF HEALTH AND HUMAN SERVICES

FOOD AND DRUG ADMINISTRATION.

DISTRICT .<0!);11;5$ A.'<a Pt10<11E NUt.llreR OATE(S) Of' INSPECTION

4 04 BNA Dr. , Bldg. 200, Ste. 5 00 05 /31/ i011 - 06 / 02/201 1

FEII'IUMIIER
Nashville, TN 37217-259,7
(615 ) 366-7801 Fax : (6151} 366-7802 3004327090
Indus try Information: wJw.fd~.gov/oc/industry
NAMi!ANO TITLE OF INDIVIDUAL TO\MiOM Rfi'QRT I~SUEO

TO: Robert Wilford Webb, III, Director of Production

FIRM N....._~ STREEo AOORESS

Cal - Maine Farms, Inc. 3280 Adams Lane

CITY. STATE. l.PCOOE, COUHT~ TYPE ESTABUSHMEHT ;NSPECTB>

Edwards, MS 3906 6 Manufacturer

This document lists observations made by the FDA represenuuive(s} during the inspection.ofyour facility. They are inspection a!
observations, and do not represent a fi nal Agency determination regarding your compliance. Ifyou have an objection regarding an
observation, or have implemented, or plan to implement, corrective action in response to an observation, you may discuss the objection or
action with the FDA represcntative(s) d(lring the inspection or submit this information to FDA at the address above. Ifyou have any
questions, please contact FDA at the phbne number and address above.

DURING AN INSPECTION OF YOUR FIRM WE OBSERVED:

OBSERVATION 1

Your written SE prevention plan lacks appropriate SE prevention measures.

Specifically, your flllll failed to hav~ written procedures that address egg testing for Salmonella Enteritidis following a
positive environmental test of the ptlllet environment.

EMPL01!1!(S) SIGNATURE /7(}" OATE ISSUEO

Amanda K . Wi lley , Inv~stigato~ ~~~~

1

SEE REVERSE Sidney M. Smith, Investigator --~;~~~~

0 6 /02/2011
OF THIS PAGE Wayne S. Fortenbe~ry , Investigator p~ .!5: -~

FORM FDA 483 (~tW} ltl!V!OUS rom ON 08SOI.ETE JNSl'tCfiONAL OBSERVA TJONS. PAGE I OF I PACES
The observations of objectionable conditions and practices listed
on the front of this form are reported:

1. Pursuant to Section 704(b) of the Federal Food, Drug and

Cosmetic Act, or

2. To assist firms inspected in complying with the Acts and

regulations enforced by the Food and Drug Administration

Section 704(b) of the Federal Food, Drug, and Cosmetic Act (21
USC 374(b)) provides:

"Upon completion of any such inspection of a factory,

warehouse, consulting laboratory, or other establishment, and
prior to leaving the premises, the officer or employee making the
inspection shall give to the owner, operator, or agent in charge a
report in writing setting forth any conditions or practices
observed by him which, in his judgement, indicate that any food,
drug, device, or cosmetic in such establishment (1) consists in
whole or in part of any filthy, putrid, or decomposed substance,
or (2) has been prepared, packed, or held under insanitary
conditions whereby it may have become contaminated with filth,
or whereby it may have been rendered injurious to health. A
copy of such report shall be sent promptly to the Secreta ."